Ribozyme-mediated reduction of the GABA(A) receptor alpha1 subunit.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• The alpha1 subunit of the GABA(A) receptor plays a crucial role in receptor function.
• Understanding the specific roles of GABA(A) receptor subunits requires methods to selectively reduce their expression.

Purpose of the Study:

• To design and validate ribozymes for reducing the expression of the alpha1 subunit of the GABA(A) receptor.
• To assess the efficacy of ribozymes in decreasing alpha1 subunit mRNA and protein levels.
• To investigate the impact of reduced alpha1 subunit expression on GABA(A) receptor properties.

Main Methods:

• Design of ribozymes targeting extracellular and cytoplasmic domains of the alpha1 subunit mRNA.
• Cloning ribozymes into a mammalian expression plasmid.
• Transfection of a human GABA(A) receptor-expressing cell line with ribozyme plasmids.
• Northern blot analysis to quantify mRNA levels.
• Western blot analysis (implied) to quantify protein levels.
• Electrophysiological recordings to assess receptor function.

Main Results:

• Ribozymes effectively cleaved target mRNA in vitro.
• Transfection with ribozymes resulted in 55-60% reduction in alpha1 mRNA levels.
• Alpha1 protein levels were reduced by 75% (cytoplasmic ribozyme) and over 90% (both ribozymes).
• GABA(A) receptor properties and potentiation by bretazenil or zolpidem remained similar in cells with reduced alpha1 expression.

Conclusions:

• Ribozymes are an effective tool for significantly reducing GABA(A) alpha1 subunit protein levels in transfected cells.
• This ribozyme strategy is a viable approach for knocking down transmitter receptor subunit proteins.
• The findings provide a foundation for applying ribozymes in transgenic mice for studying receptor function.